GEN’s first-ever A-List for synthetic biology ranks the five largest public companies by their 2020 revenues, and the five largest private companies by the total capital they have raised.
CAMBRIDGE, Mass., Dec. 12, 2021 Beam Therapeutics Inc. , a biotechnology company developing precision genetic medicines through base editing, today shared a three-stage, long-term. | December 12, 2021
Beam Therapeutics Outlines Long-term Strategy for Base Editing Programs in Sickle Cell Disease and Provides Preclinical Data Updates at ASH forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
ReCode Therapeutics closed an $80 million Series B round of financing that included Pfizer and Sanofi as investors. The startup’s technology uses lipid nanoparticles to deliver genetic medicines, and its two lead programs are for rare lung disorders.
Finch Therapeutics Announces the Appointment of Marc Blaustein as Chief Operating Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.